Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470. - Wikidata - wikimedia - TriplyDB

Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470.

Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470.

http://www.wikidata.org/entity/Q44775111

about

Nanotechnology-mediated targeting of tumor angiogenesis Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?An orally delivered small-molecule formulation with antiangiogenic and anticancer activity Antiangiogenic gene therapy of cancer: recent developments Anti-angiogenic gene therapy in the treatment of malignant gliomas The Role of CC-Chemokines in the Regulation of Angiogenesis Angiostatin regulates the expression of antiangiogenic and proapoptotic pathways via targeted inhibition of mitochondrial proteins Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers.Targeting angiogenesis-dependent calcified neoplasms using combined polymer therapeutics Optical imaging-guided cancer therapy with fluorescent nanoparticles Activation of the planar cell polarity formin DAAM1 leads to inhibition of endothelial cell proliferation, migration, and angiogenesis.Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analogues.Robust substrate profiling method reveals striking differences in specificities of serum and lung fluid proteases.Angiogenesis inhibitors: current strategies and future prospects.Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma.The potential of nanomedicine therapies to treat neovascular disease in the retina.Inhibition of brain tumor growth by intravenous poly (β-L-malic acid) nanobioconjugate with pH-dependent drug release [corrected]Anti-angiogenic treatment strategies for the therapy of endometriosis.Judah Folkman, a pioneer in the study of angiogenesis A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy.Endometriosis: alternative methods of medical treatment.Protease-activated drug development.Tumour angiogenesis, vascular biology and enhanced drug delivery.Reductively responsive siRNA-conjugated hydrogel nanoparticles for gene silencing.Drugs to suppress cough.Polymers for drug delivery systems.Inhibition of laminin-8 in vivo using a novel poly(malic acid)-based carrier reduces glioma angiogenesis.Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo Polymer conjugates as anticancer nanomedicines.Cathepsin B-cleavable doxorubicin prodrugs for targeted cancer therapy (Review)Polymer therapeutics--polymers as drugs, drug and protein conjugates and gene delivery systems: past, present and future opportunities.Exploiting nanotechnology to target cancer Polymer-drug conjugates as modulators of cellular apoptosis.Nanovehicular intracellular delivery systems.Novel technologies for antiangiogenic drug delivery in the brain.Influence of levamisole and other angiogenesis inhibitors on angiogenesis and endothelial cell morphology in vitro In vivo/ex vivo and in situ assays used in cancer research: a brief review.Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel.Discovery of anticancer agents of diverse natural origin.

P2860

Q21195857-8BBDD860-5C7E-45A7-B519-DC88E8AFE370 Q24599399-DC1CDC39-A98D-4608-8B95-FAB431ECA616 Q24649290-E74CC68F-365A-44BD-9BD1-94CAFDD99B98 Q24803786-537D5BC7-94DD-4F86-AB88-AD742CAB08C8 Q26866276-135414ED-A34C-4595-B239-7A980E8ED26A Q28077024-BB5E432F-1FD7-4A10-A6B2-13BFBF53279C Q30490006-098B3A41-9847-4F6C-8A07-4C2234873334 Q33235069-4C545932-53AB-4231-9633-016BDBDA0A78 Q33432776-8A1C7D3D-B878-4581-A565-E79EE11133D1 Q33731037-422B8EF1-C36B-4BF7-8BF1-0DAE76948B4F Q33859624-0E3A8246-9371-46EE-846A-54B077EB1E73 Q33913718-D332EE26-9A6B-4AD2-90E9-8BD627303153 Q33921024-BCD38B85-82E9-4053-9A78-106B863599E9 Q33977518-19AF868B-64BB-4A3B-8194-69003C48E13C Q34056376-3AF463E9-F82D-4CA6-8BA5-5E5E50554E27 Q34066263-C6C73A6C-74F2-4D4E-BF72-CDB1A5BB2641 Q34220590-AC1E176C-9A1D-4CD4-BB73-6A1CAE9FAD56 Q34241230-1FB45A64-BACB-4B00-AA15-B3AACC38586B Q34283036-DD3EF162-F4BF-4481-B1CB-2444AA1D40CF Q34745454-98F06C19-C975-4175-AD3A-28DFF8C825CA Q35088412-5FE42788-A6B9-4C41-89F2-3B5CD20A28BE Q35668144-6451D5F1-3B55-495D-8C02-E07A2A93FE5B Q35811508-D60F598D-B152-4A44-9B72-18DACF9B142D Q35931998-85FC87CA-701B-4650-9EE8-3BBEEFCCEE93 Q35975665-B42529FE-180B-4440-B74F-CEEB418A0629 Q36040853-9C5D7DF3-8DB2-4978-B152-3826857DAE1E Q36225509-63D23730-E1D5-4835-BC1B-CB1DBA57EA9E Q36367352-A6FB59EA-792A-4BBA-9297-0F041A03D163 Q36395163-16C2054C-809A-460D-9D76-E34C5B297377 Q36561667-D8926096-60E6-4FFA-8DD3-C2F9B884B3D0 Q36643541-4FC5CE27-8789-4AE5-AC6A-1CCFC56A7933 Q36648444-B5B0805C-4490-4EEE-80ED-39CE01FAAB23 Q36779386-A0016E22-2A3D-438E-8D33-957AA18D03B0 Q36956674-AEAD8013-6367-46EE-99FF-D9C763452FC8 Q37058812-B5DD50D7-57D1-4CF3-BDAC-BC0E33176464 Q37186246-5F81B32E-6B7D-4BA1-895E-132FFBB8FCB2 Q37226482-10A566B6-8419-48E2-88F3-EA3CBEE30A0D Q37355404-6A902E9B-1CD4-489C-99DF-CD8A43FFABAC Q37378199-23612D80-8EF2-4734-B54E-E5FADFD32CA1 Q37394746-25C9529D-03B3-4A43-81BD-2802711CD631

P2860

Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470.

http://www.wikidata.org/entity/Q44775111

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470.

@en

Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470.

@nl

type

label

Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470.

@en

Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470.

@nl

prefLabel

Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470.

@en

Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470.

@nl

P1433

Q44775111-C714EBC2-F1E2-4682-829D-5F827006D85C

P1476

Q44775111-8C019819-C209-4AF0-BA57-3A2E403077CD

P2093

Q44775111-154BE543-B9FA-4996-866E-6FA88796C312

Q44775111-5AFCD6B1-5F0F-4DA0-8CF7-FAEF2E701FA8

Q44775111-6BA1D447-2F4D-4F69-B6F6-08764B9D1277

Q44775111-8E22A18A-3898-4177-9A9F-F5CC2DBC4AF2

Q44775111-CC126944-B882-4649-A43F-68BDE785BE59

Q44775111-D961C3C9-9309-4663-8590-873AE55F10E7

Q44775111-F937FC06-419D-4F58-B193-08F2938BDA64

P2860

Q44775111-0DE8C892-F58D-43A9-BB75-18FFB77570C8

Q44775111-11E5F588-377F-4929-B77B-A67DF26B0ABB

Q44775111-20BE5501-B689-49CB-A6DC-C40EDA8214EE

Q44775111-2665A10A-1C42-463F-B6EE-08348FAAA1C4

Q44775111-28282BD2-D22E-4922-9F87-9DDF093E4B83

Q44775111-360EC3F7-13D9-4E69-B096-67B851FF7A72

Q44775111-55693138-9D61-4A5D-8958-89AE69A77930

Q44775111-57B3D6A0-4930-41ED-83F8-0601A466B6B0

Q44775111-5C5D90EE-2E48-4359-B739-CF6246E6D530

Q44775111-5DEF3B02-C318-47A0-BC66-E3131D880545

P2888

Q44775111-44FAF561-0E85-49BF-A845-D0ECC4FE8E35

P304

Q44775111-FF56FF66-0650-41D2-81F1-583A79B1717B

P31

Q44775111-8265A723-74C8-42A6-B197-ABA04AEA6B6A

P356

Q44775111-3598571E-B588-400B-9E29-6B5ABAF0AC0D

P407

Q44775111-52A0E8DF-8F73-4BE2-85AD-F540E4B2E215

P433

Q44775111-EC438439-A552-4028-8A72-693036032F96

P478

Q44775111-187195B2-F96B-42BB-BE54-712FCE597C51

P50

Q44775111-840FB1D4-A202-4473-A846-FEC7E25E4E54

P577

Q44775111-9BC6C107-9C7F-4BAB-9BF0-3C0FD9A2B298

P5875

Q44775111-74D1DDC6-0F87-439E-9030-A9046508367A

P698

Q44775111-89831A87-1753-4933-9671-3A6471BBDDB7

P356

P1433

Nature Medicine

P1476

Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470.

@en

P2093

Arin K Greene

http://www.w3.org/2001/XMLSchema#string

David A Sampson

http://www.w3.org/2001/XMLSchema#string

Gabriel Corfas

http://www.w3.org/2001/XMLSchema#string

Hai T Tran

http://www.w3.org/2001/XMLSchema#string

John W Davies

http://www.w3.org/2001/XMLSchema#string

Judah Folkman

http://www.w3.org/2001/XMLSchema#string

Mark Puder

http://www.w3.org/2001/XMLSchema#string

P2860

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1

Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

Assay of TNP-470 and its two major metabolites in human plasma by high-performance liquid chromatography-mass spectrometry.

Long-term culture of capillary endothelial cells

Adipose tissue mass can be regulated through the vasculature.

Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin.

Angiogenesis inhibitors in lung cancer.

TNP-470 antiangiogenic therapy for advanced murine neuroblastoma.

P2888

P304

255-261

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM1002

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Ronit Satchi-Fainaro

P577

2004-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6602682

http://www.w3.org/2001/XMLSchema#string

P698

14981512

http://www.w3.org/2001/XMLSchema#string